Skip to main content
Top
Published in: Journal of General Internal Medicine 3/2019

01-03-2019 | Original Research

A Retrospective Study of Administrative Data to Identify High-Need Medicare Beneficiaries at Risk of Dying and Being Hospitalized

Authors: Emmanuelle Bélanger, PhD, Benjamin Silver, PhD, David J. Meyers, MPH, Momotazur Rahman, PhD, Amit Kumar, PhD, Cyrus Kosar, MA, Vincent Mor, PhD

Published in: Journal of General Internal Medicine | Issue 3/2019

Login to get access

Abstract

Background

Developing a definition of what constitutes high need among Medicare beneficiaries using administrative data is an important prerequisite to evaluating value-based payment reforms. While various definitions of high need exist, their predictive validity for different patient outcomes in the following year has not been systematically assessed for both fee-for-service (FFS) and Medicare Advantage (MA) beneficiaries.

Objective

To develop a definition of high need using administrative data in 2014 and to examine its predictive validity for patient outcomes in 2015 as compared to alternative definitions for both FFS and MA beneficiaries.

Design

Retrospective cohort study of national Medicare claims and post-acute assessment data.

Participants

All Medicare beneficiaries in 2014 who survived until the end of the year (n = 54,717,039).

Main Measures

Two or more complex conditions, 6 or more chronic conditions, acute or post-acute health services utilization, indicators of frailty, complete dependency in mobility or in any activities of daily living in post-acute care assessments, hospitalization, mortality, days in community, Medicare expenditures.

Key Results

Based on our definition of high-need patients, 13.17% of FFS and 8.85% of MA beneficiaries were identified as high need in 2014. High-need FFS patients had mortality rates 7.1 times higher (16.23% vs. 2.27%) and hospitalization rates 3.4 times higher (40.69 vs. 12.03) in 2015 compared to other beneficiaries. Competing high-need definitions all had good specificity (≥ 0.88). Having 3 or more Hierarchical Chronic Conditions yielded a good positive predictive value for hospitalization, at 0.50, but only identified 19.71% of FFS beneficiaries hospitalized and 28.46% of FFS decedents that year as high need, as opposed to 33.92% and 51.98% for the new definition. Results were similar for MA beneficiaries.

Conclusions

The proposed high-need definition has better sensitivity and yields a sample of almost 5 million FFS and 1.5 million MA beneficiaries, facilitating outcome performance comparisons across health systems.
Appendix
Available only for authorised users
Literature
3.
go back to reference Anderson GF, Ballreich J, Bleich S, Boyd C, DuGoff E, Leff B, Salzburg C, Wolff J. Attributes common to programs that successfully treat high-need, high-cost individuals. Am J Manage Care. 2015;21(11):e597–600. Anderson GF, Ballreich J, Bleich S, Boyd C, DuGoff E, Leff B, Salzburg C, Wolff J. Attributes common to programs that successfully treat high-need, high-cost individuals. Am J Manage Care. 2015;21(11):e597–600.
4.
go back to reference Blumenthal D, Chernof B, Fulmer T, Lumpkin J, Selberg J. Caring for high-need, high-cost patients - an urgent priority. N Engl J Med. 2016;375(10):909–11.CrossRef Blumenthal D, Chernof B, Fulmer T, Lumpkin J, Selberg J. Caring for high-need, high-cost patients - an urgent priority. N Engl J Med. 2016;375(10):909–11.CrossRef
6.
go back to reference Joynt KE, Figueroa JF, Beaulieu N, Wild RC, Orav EJ, Jha AK. Segmenting high-cost Medicare patients into potentially actionable cohorts. Healthc. 2017;5(1–2):62–7.CrossRef Joynt KE, Figueroa JF, Beaulieu N, Wild RC, Orav EJ, Jha AK. Segmenting high-cost Medicare patients into potentially actionable cohorts. Healthc. 2017;5(1–2):62–7.CrossRef
8.
go back to reference Colla CH, Lewis VA, Kao L-S, O'Malley AJ, Chang C-H, Fisher ES. Association between Medicare Accountable Care Organization implementation and spending among clinically vulnerable beneficiaries. JAMA Intern Med. 2016;176(8):1167–75. Accessed 15 October 2017.CrossRef Colla CH, Lewis VA, Kao L-S, O'Malley AJ, Chang C-H, Fisher ES. Association between Medicare Accountable Care Organization implementation and spending among clinically vulnerable beneficiaries. JAMA Intern Med. 2016;176(8):1167–75. Accessed 15 October 2017.CrossRef
13.
go back to reference Figueroa JF, Joynt Maddox KE, Beaulieu N, Wild RC, Jha AK. Concentration of potentially preventable spending among high-cost Medicare subpopulations: an observational study. Ann Intern Med. 2017;167(10):706–13.CrossRef Figueroa JF, Joynt Maddox KE, Beaulieu N, Wild RC, Jha AK. Concentration of potentially preventable spending among high-cost Medicare subpopulations: an observational study. Ann Intern Med. 2017;167(10):706–13.CrossRef
14.
go back to reference Beaulieu ND, Joynt KE, Wild R, Jha AK. Concentration of high-cost patients in hospitals and markets. Am J Manag Care. 2017;23(4):233–8.PubMed Beaulieu ND, Joynt KE, Wild R, Jha AK. Concentration of high-cost patients in hospitals and markets. Am J Manag Care. 2017;23(4):233–8.PubMed
15.
go back to reference Kumar A, Karmarkar AM, Graham JE, Resnik L, Tan A, Deutsch A, et al. Comorbidity indices versus function as potential predictors of 30-day readmission in older patients following postacute rehabilitation. J Gerontol A Biol Sci Med Sci. 2017;72(2):223–8. Kumar A, Karmarkar AM, Graham JE, Resnik L, Tan A, Deutsch A, et al. Comorbidity indices versus function as potential predictors of 30-day readmission in older patients following postacute rehabilitation. J Gerontol A Biol Sci Med Sci. 2017;72(2):223–8.
16.
go back to reference Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.CrossRef Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.CrossRef
17.
go back to reference Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234–40.CrossRef Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234–40.CrossRef
18.
go back to reference Sharabiani MTA, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50(12):1109–18.CrossRef Sharabiani MTA, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50(12):1109–18.CrossRef
19.
go back to reference Huckfeldt PJ, Escarce JJ, Rabideau B, Karaca-Mandic P, Sood N. Less intense postacute care, better outcomes for enrollees in Medicare Advantage than those in Fee-For-Service. Health Aff (Millwood). 2017;36(1):91–100.CrossRef Huckfeldt PJ, Escarce JJ, Rabideau B, Karaca-Mandic P, Sood N. Less intense postacute care, better outcomes for enrollees in Medicare Advantage than those in Fee-For-Service. Health Aff (Millwood). 2017;36(1):91–100.CrossRef
20.
go back to reference McWilliams JM, Schwartz AL. Focusing on high-cost patients — the key to addressing high costs? N Engl J Med. 2017;376(9):807.CrossRef McWilliams JM, Schwartz AL. Focusing on high-cost patients — the key to addressing high costs? N Engl J Med. 2017;376(9):807.CrossRef
Metadata
Title
A Retrospective Study of Administrative Data to Identify High-Need Medicare Beneficiaries at Risk of Dying and Being Hospitalized
Authors
Emmanuelle Bélanger, PhD
Benjamin Silver, PhD
David J. Meyers, MPH
Momotazur Rahman, PhD
Amit Kumar, PhD
Cyrus Kosar, MA
Vincent Mor, PhD
Publication date
01-03-2019
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 3/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4781-3

Other articles of this Issue 3/2019

Journal of General Internal Medicine 3/2019 Go to the issue

Clinical Practice: Clinical Images

Chickenpox in a Vaccinated Adult

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.